Last mentioned: Mar 13, 2026
Shirley Basin Outlook
Expected commencement of site preparation for the second production hub.
Production Ramp
Achieved target flow rates for full-scale ISR operations.
Contract Milestone
Secured additional long-term sales agreement with a leading utility.
Wellfield Expansion
Commenced construction of new header houses at Lost Creek.
Guardian Pharmacy Services (GRDN) reported a significant earnings beat for Q4 2025, posting an EPS of $0.3289 against expectations of $0.2675. The results highlight the company's operational strength in the long-term care pharmacy sector, while simultaneous reports from Ur-Energy (URG) signal continued momentum in the uranium production market.
Ur-Energy Inc. (URG) reported its Q4 2025 results, signaling a definitive shift from development to active production at its Lost Creek facility. The company is positioning itself as a critical supplier for the resurgent U.S. nuclear sector, driven by data center energy demands and a legislative push for domestic fuel sources.
Guardian Pharmacy Services (NYSE:GRDN) significantly outperformed analyst expectations in its fourth-quarter 2025 earnings report, posting an EPS of $0.3289 against a consensus of $0.2675. The results underscore the resilience of the company's decentralized 'local-autonomy' model within the high-growth long-term care pharmacy sector.
Guardian Pharmacy Services (NYSE:GRDN) reported a robust Q4 2025 performance, with an EPS of $0.3289 significantly exceeding analyst expectations of $0.2675. This performance highlights the company's operational efficiency and its strategic positioning within the expanding long-term care pharmacy sector.